77H-11669-92327
3 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 981 / WA
- Registered
- 2021-06-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-20
Dose 1 — Pfizer-BioNTech
-
2021-06-10
Dose 2 — Pfizer-BioNTech
-
2021-06-15
Registered in v-safe
- 2021-06-15
- 2021-06-16
- 2021-06-17
- 2021-06-24
- 2021-07-03
- 2021-07-08
- 2021-07-15
- 2021-07-22
- 2021-09-09
-
2021-11-19
Dose 3 — Pfizer-BioNTech
- 2021-12-09
- 2021-12-10
- 2021-12-17
-
2021-12-24
Survey response — day 35, dose 3MedDRA: Fatigue, Headache, Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Common cold - headache, runny nose, fatigue, mild sore throatMedDRA releases: 2024-11 · check-in free text available
- 2021-12-31
- 2022-02-18
- 2022-05-20
- 2022-11-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-20 | Pfizer-BioNTech | |
| 2 | 2021-06-10 | Pfizer-BioNTech | |
| 3 | 2021-11-19 | Pfizer-BioNTech | No |
Free text
Release 10 — day 35, dose 3
Symptoms: Common cold - headache, runny nose, fatigue, mild sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release